India, March 18 -- Sun Pharmaceutical Industries announced the successful completion of its 100% acquisition of Antibe Therapeutics Inc., Canada, through its subsidiary TARO Pharmaceuticals Inc.
The acquisition, initially disclosed on January 16, 2025, was finalized for a total consideration of CAD 4.5 million.
Published by HT Digital Content Services with permission from Dion Global Solutions Limited....